Owkin has raised $316M across 6 funding rounds, plus 1 undated round.
Owkin is backed by Bpifrance Large Ventures, GV, NJF Capital, Cathay Innovation and F-Prime. The mix pairs Google's venture arm with a French public investment fund, reflecting the company's French-American structure.
6 funding rounds, the latest highlighted.
Owkin was founded in 2016, France.
No date is disclosed for this round.
Acequia Capital, B Capital Group, Firstminute Capital, Pioneer Square Labs, Third Kind Ventures. $2M raised.
A primary round — the company sells new shares to investors it selects. $5M raised, led by Adam Ghobarah.
.406 Ventures, 4BIO Capital, Cathay Innovation, Eight Roads Ventures, F Prime Capital, Granite Asia, Scale Venture Partners. $13M raised.
.406 Ventures, 4BIO Capital, Eight Roads Ventures, F Prime Capital, Scale Venture Partners, GV, Macsf. $25M raised, led by Mubadala Capital.
All previous investors. $180M raised, led by Sanofi.
Previous investors. $80M raised, led by Bristol Myers Squibb.
No filing has been made.
6 dated rounds, newest first.
GVNNJF CapitalCCathay InnovationFF-PrimeEEight Roads VenturesThe closest biotech / ai peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Owkin is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
